Xie Yili Kevin 4
4 · HUMANIGEN, INC · Filed Oct 20, 2021
Insider Transaction Report
Form 4
HUMANIGEN, INCHGEN
Xie Yili Kevin
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2021-10-19+42,866→ 42,866 totalExercise: $6.56From: 2022-03-31Exp: 2031-10-18→ Common Stock (42,866 underlying)
Footnotes (1)
- [F1]The option vests in 12 ratable quarterly installments commencing March 31, 2022.
Signature
/s/ Timothy E. Morris, Attorney-in-Fact|2021-10-20